Myszkowski Kenneth Allen - Insider Transactions
Insider Type
individual
Companies
1
Average
358,576
Total Txns
8
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 4 | -4 | 0.00 | 1,975,509.60 | -1,975,509.60 |
| 2025 | 0 | 4 | -4 | 0.00 | 893,095.40 | -893,095.40 |
| Total: | 0 | 8 | 8 | 0.00 | 2,868,605.00 | -2,868,605.00 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. Common Stock US04280A1007 |
19.68 USD |
17,765 Sold |
349,615 USD |
04/01/2025 | 06/01/2025 |
| Arrowhead Pharmaceuticals, Inc. Common Stock US04280A1007 |
20.10 USD |
9,402 Sold |
188,980 USD |
04/01/2025 | 06/01/2025 |
| Arrowhead Pharmaceuticals, Inc. Common Stock US04280A1007 |
19.70 USD |
8,000 Sold |
157,600 USD |
04/01/2025 | 07/01/2025 |
| Arrowhead Pharmaceuticals, Inc. Common Stock US04280A1007 |
19.69 USD |
10,000 Sold |
196,900 USD |
04/01/2025 | 07/01/2025 |
| Arrowhead Pharmaceuticals, Inc. Common Stock US04280A1007 |
35.19 USD |
40,000 Sold |
1,407,600 USD |
06/03/2024 | 06/03/2024 |
| Arrowhead Pharmaceuticals, Inc. Common Stock US04280A1007 |
34.04 USD |
1,400 Sold |
47,656 USD |
04/01/2024 | 05/01/2024 |
| Arrowhead Pharmaceuticals, Inc. Common Stock US04280A1007 |
34.97 USD |
5,800 Sold |
202,826 USD |
04/01/2024 | 05/01/2024 |
| Arrowhead Pharmaceuticals, Inc. Common Stock US04280A1007 |
35.65 USD |
8,904 Sold |
317,428 USD |
04/01/2024 | 05/01/2024 |